Chronopharmacology and chronotherapy of cardiovascular medications: relevance to prevention and treatment of coronary heart disease (Q33546228)

27 July 2017

1 reference

title

Chronopharmacology and chronotherapy of cardiovascular medications: relevance to prevention and treatment of coronary heart disease (English)

1 reference

27 July 2017

1 reference

1 reference

coronary artery disease

1 reference

1 reference

Portaluppi F

2

0 references

author name string

Smolensky MH

series ordinal

1

1 reference

PubMed ID

10097242

27 July 2017

language of work or name

English

0 references

publication date

1 April 1999

1 reference

27 July 2017

American Heart Journal

1 reference

27 July 2017

137

1 reference

27 July 2017

4 Pt 2

1 reference

27 July 2017

S14-S24

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970392-3

27 July 2017

1 reference

Circadian timekeeping in health and disease. Part 1. Basic properties of circadian pacemakers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970392-3

Circadian Rhythm of Blood Pressure: Internal and External Time Triggers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970392-3

Altered circadian rhythms of blood pressure and heart rate in non-hemodialysis chronic renal failure.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970392-3

Blunted nocturnal fall in blood pressure in hypertensive women with future cardiovascular morbid events

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970392-3

Nondipping of nocturnal blood pressure is related to urinary albumin excretion rate in patients with type 2 diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970392-3

Nocturnal fall of blood pressure and silent cerebrovascular damage in elderly hypertensive patients. Advanced silent cerebrovascular damage in extreme dippers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970392-3

Medical chronobiology: concepts and applications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970392-3

Circadian variation and triggers of onset of acute cardiovascular disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970392-3

Meta-analysis of the morning excess of acute myocardial infarction and sudden cardiac death

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970392-3

Circadian variation in the frequency of sudden cardiac death

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970392-3

Modification of the circadian pattern of ventricular tachyarrhythmias by beta-blocker therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970392-3

Circadian variation in defibrillation energy requirements

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970392-3

Relation of circadian ventricular ectopic activity to cardiac mortality. CAST Investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970392-3

Temporal Patterns of Stroke Onset

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970392-3

Diurnal variation in occurrence of strokes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970392-3

Circadian rhythms and coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970392-3

Circadian variation in coronary tone in patients with stable angina. Protective role of the endothelium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970392-3

Nocturnal Asthma and Changes in Circulating Epinephrine, Histamine, and Cortisol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970392-3

Circadian changes of drug disposition in man.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970392-3

Circadian changes in the pharmacokinetics and cardiovascular effects of oral propranolol in healthy subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970392-3

Cardiovascular effects, pharmacokinetics, and converting enzyme inhibition of enalapril after morning versus evening administration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970392-3

Clinical chronopharmacology of oral sustained-release isosorbide-5-mononitrate in healthy subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970392-3

Diurnal variation in exercise responses in angina pectoris

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970392-3

The effects of beta-blocker therapy on diurnal variation of blood pressure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970392-3

The 24-hour ambulatory blood pressure profile with verapamil

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970392-3

Administration-time-dependent effects of diltiazem on the 24-hour blood pressure profile of essential hypertension patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970392-3

Time-dependent effect of isradipine on the nocturnal hypertension in chronic renal failure*

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970392-3

Can an angiotensin-converting enzyme inhibitor with a short half-life effectively lower blood pressure for 24 hours?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970392-3

Circadian variation of exercise capacity in patients with Prinzmetal's variant angina: role of exercise-induced coronary arterial spasm

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970392-3

Measurement of heparin in plasma: influence of inter-subject and circadian variability in heparin sensitivity according to method

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970392-3

Circadian variation in the efficacy of tissue-type plasminogen activator.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970392-3

Circadian variation in the success rate of intracoronary thrombolysis for acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970392-3

STUDIES ON AN INTERMITTENT CORTICOSTEROID DOSAGE REGIMEN

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970392-3

Ranitidine 150 mg twice daily vs 300 mg nightly in treatment of duodenal ulcers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970392-3

The effect of food, time of dosing, and body position on the pharmacokinetics and pharmacodynamics of verapamil and norverapamil

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970392-3

Nocturnal dosing of a novel delivery system of verapamil for systemic hypertension. Verapamil Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970392-3

Comparison of effects of controlled onset extended release verapamil at bedtime and nifedipine gastrointestinal therapeutic system on arising on early morning blood pressure, heart rate, and the heart rate-blood pressure product

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970392-3

Nocturnal blood pressure and silent cerebrovascular lesions in elderly Japanese.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970392-3

Nocturnal arterial hypotension and its role in optic nerve head and ocular ischemic disorders

7 January 2021

2 references

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970392-3

7 January 2021

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970392-3

inferred from DOI database lookup

7 January 2021

based on heuristic

Effects of controlled-onset extended-release verapamil on nocturnal blood pressure (dippers versus nondippers). COER-Verapamil Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970392-3

Circadian variation of transient myocardial ischemia in patients with coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970392-3

The pathophysiology of the onset of morning cardiovascular events

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970392-3

Propranolol and the morning increase in the frequency of sudden cardiac death (BHAT Study)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970392-3

Effect of nifedipine on total ischemic activity and circadian distribution of myocardial ischemic episodes in angina pectoris

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970392-3

Attenuation of the circadian patterns of myocardial ischemia with nifedipine GITS in patients with chronic stable angina. N-CAP Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970392-3

Increased morning incidence of myocardial infarction in the ISAM Study: absence with prior beta-adrenergic blockade. ISAM Study Group.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970392-3

Placebo-controlled evaluation of three doses of a controlled-onset, extended-release formulation of verapamil in the treatment of stable angina pectoris

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970392-3

Comparison of controlled-onset, extended-release verapamil with amlodipine and amlodipine plus atenolol on exercise performance and ambulatory ischemia in patients with chronic stable angina pectoris

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970392-3

Pathophysiology of silent myocardial ischemia during daily life. Hemodynamic evaluation by simultaneous electrocardiographic and blood pressure monitoring

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970392-3

Effect of verapamil on mortality and major events after acute myocardial infarction (the Danish Verapamil Infarction Trial II--DAVIT II)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970392-3

Rationale and design for the Controlled ONset Verapamil INvestigation of Cardiovascular Endpoints (CONVINCE) Trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970392-3

Circadian changes in anticoagulant effect of heparin infused at a constant rate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970392-3

10.1016/S0002-8703(99)70392-3

7 January 2021

Identifiers

DOI

1 reference

27 July 2017

1 reference

PubMed ID

10097242